Vanguard Group’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-310,528
Closed -$6.2M 3933
2013
Q3
$6.2M Buy
310,528
+1,007
+0.3% +$16.4K ﹤0.01% 2627
2013
Q2
$4.56M Buy
+309,521
New +$4.42M ﹤0.01% 2716

Vanguard Group's ROCM Position: Q4 2013 in Review

Vanguard Group sold out of ROCHESTER MEDICAL CORP (ROCM) in Q4 2013, closing a stake of 310,528 shares — an estimated $6.2M sold.

Vanguard Group first reported a position in ROCM in Q2 2013 and held it in 2 quarters. The position peaked at $6.2M in Q3 2013. 0 funds tracked by Wall St. Rank hold ROCM as of Q4 2013.

  • Vanguard Group reported no remaining ROCHESTER MEDICAL CORP position as of Q4 2013 after selling out during the quarter.
  • Vanguard Group sold 310,528 ROCHESTER MEDICAL CORP shares in Q4 2013, an estimated $6.2M.
  • Vanguard Group first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 2 quarters.
  • Vanguard Group's ROCHESTER MEDICAL CORP position peaked at $6.2M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q4 2013.

Based on Vanguard Group's 13F filing for Q4 2013, filed 12 Feb 2014.